🚀 The countdown to the launch of our new websites has begun! 🚀
Get ready for a transformative educational experience developed in collaboration with world-renowned faculty. Our new websites are designed to optimise your time, enhance professional growth, and ultimately improve patient outcomes. 💡
Our key features allow you to save your video progress, track CME credits, add personalised learning notes, and receive updates from course leaders and expert faculty. Be the first to hear about exciting new interactive learning opportunities!
Register now to see how we are driving positive change in the medical education industry with the expertise of leading faculty.💡🔗https://www.touchendocrinology.com/your-free-10-minutes-at-a-time-medical-education/
#MedEd #MedComms #NextGenIME #NextGenMedComms #NextGenWeb #DigitalRevolution #InnovationUnleashed #StayTuned
🚀 The countdown to the launch of our new websites has begun! 🚀
Get ready for a transformative educational experience developed in collaboration with world-renowned faculty. Our new websites are designed to optimise your time, enhance professional growth, and ultimately improve patient outcomes. 💡
Our key features allow you to save your video progress, track CME credits, add personalised learning notes, and receive updates from course leaders and expert faculty. Be the first to hear about exciting new interactive learning opportunities!
Register now to see how we are driving positive change in the medical education industry with the expertise of leading faculty.💡🔗https://www.touchendocrinology.com/your-free-10-minutes-at-a-time-medical-education/
#MedEd #MedComms #NextGenIME #NextGenMedComms #NextGenWeb #DigitalRevolution #InnovationUnleashed #StayTuned
Happy New Year!
We’d like to raise a glass to all our supporters, editorial boards, Editors-in-Chief, medical societies, expert faculty and patient advocates…
Here’s to another year of creating outstanding touchENDOCRINOLOGY education for clinicians worldwide!
In the spirit of the festive season, we want to say a special “thank you” to all the supporters, editorial boards, Editors-in-Chief, medical societies, expert faculty and patient advocates who helped make 2022 such a success.
Here’s to you – and lots more to come in 2023!
Endocrinology and primary care experts, Prof. Peter Rossing and Dr Eden Miller, discuss key considerations for addressing cardiorenal outcomes in patients with CKD/T2D.
Watch now: bit.ly/3FfgT4U
-----------
This activity is funded by an independent medical education grant from Bayer and is jointly provided by USF Health and touchIME.
#CardiovascularRisk
#CardiovascularDisease
#HeartFailure
#PreventiveCardiology
#Stroke
#MyocardialInfarction
#ChronicKidneyDisease
#Diabetes
#Type2Diabetes
This week we are celebrating #PeerReviewWeek!
How can peer review help support #researchintegrity?
Watch below to find out more 👇
Register here to learn more about our journals: http://ow.ly/KE5k50KNF97
Experts in paediatric endocrinology, Dr Nadia Merchant and Dr Andrew Dauber, discuss the physiology of normal and abnormal bone growth, and the assessment and treatment of achondroplasia.
Watch now: http://ow.ly/GOXX50KbBvy
#endocrinology
#achondroplasia
#paediatric
#MedEd
#BoneGrowth
#GrowthCharts
#GROWUPSTRONGER
This activity is funded by an independent medical education grant from BioMarin and is jointly provided by USF Health and touchIME.
A MDT of diabetes specialists and a patient advocate share their perspectives on GLP-1 RA therapies, including the data supporting their use, managing side effects, and their role in the T2D management pathway.
Watch now: http://ow.ly/f2sH50IJA5g
Klinikum der Ruhr-Universität Bochum
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
#type2diabetes
#T2D
#Cardiovascularrisk
#GLP1
#Diabetes
#GLP1RA
#primarycare
#sideeffects
#patienteducation
#weightloss
Join our leading specialists within a MDT, plus a patient, as they discuss the future for glycemic control and weight loss in patients with T2D and obesity, with a focus on dual-agonist therapy and patient education
Watch here: http://ow.ly/eRyh50IuJc3
MultiCare Health System
Scripps Health
Salute Nutrition, PLLC
This activity is provided by an independent medical education grant from Eli Lilly.
This activity is jointly provided by USF Health and touchIME.
#endocrinology
#Diabetes
#Obesity
#Cardiovascularrisk
#MDT
#incretineffect
#diabeteseducation
#dualagonists
A MDT of diabetes specialists and a patient advocate share their perspectives on GLP-1 RA therapies, including the data supporting their use, managing side effects, and their role in the T2D management pathway.
Watch now: http://ow.ly/f2sH50IJA5g
Klinikum der Ruhr-Universität Bochum
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
#type2diabetes
#T2D
#Cardiovascularrisk
#GLP1
#Diabetes
#GLP1RA
#primarycare
#sideeffects
#patienteducation
#weightloss
Join our leading specialists within a MDT, plus a patient, as they discuss the future for glycemic control and weight loss in patients with T2D and obesity, with a focus on dual-agonist therapy and patient education
Watch here: http://ow.ly/eRyh50IuJc3
MultiCare Health System
Scripps Health
Salute Nutrition, PLLC
This activity is provided by an independent medical education grant from Eli Lilly.
This activity is jointly provided by USF Health and touchIME.
#endocrinology
#Diabetes
#Obesity
#Cardiovascularrisk
#MDT
#incretineffect
#diabeteseducation
#dualagonists
A MDT of diabetes specialists and a patient advocate share their perspectives on GLP-1 RA therapies, including the data supporting their use, managing side effects, and their role in the T2D management pathway.
Watch now: http://ow.ly/f2sH50IJA5g
Klinikum der Ruhr-Universität Bochum
This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
#type2diabetes
#T2D
#Cardiovascularrisk
#GLP1
#Diabetes
#GLP1RA
#primarycare
#sideeffects
#patienteducation
#weightloss
You could be published in touchREVIEWS in Endocrinology in just 8-12 weeks.
Medical authors, clinicians and HCPs trust Touch because:
✅Our publishing guidelines are rigorous, compliant with COPE, GPP3 and ICMJE guidelines.
✅Our double-blind review process is thorough and fast, with 450+ faculty on-hand.
✅Our journals are ethically sound, clinically balanced and internationally respected.
✅Our average turnaround time from submission to publication is rapid at around 8-12 weeks.
Worthy medical research deserves a worthy home - find out more today: http://ow.ly/wAC450IxXsj
Interview Part 3: Duke Al recites ‘If It Wasn’t for You’, a tribute to those who discovered #insulin.
Plus, artist Dr Sarah Ali explains the impact that she hopes Bitter Sweet will have for charities and on the #diabetes community.
Watch: http://ow.ly/upce50Ix6iQ
#100YearsOfInsulin #T1D
Interview Part 2: Watch Poet Duke Al discuss the messages behind the poems in his book Bitter Sweet, and his hopes for their impact upon people living with #T1D, their friends and family, and the #diabetes healthcare community: http://ow.ly/69Zl50Ix66S
#100YearsOfInsulin #Insulin
Interview Part 1: The inspiration behind Bitter Sweet, a groundbreaking book of poetry on living with type 1 #diabetes (#T1D).
Watch author Duke Al and artist Dr Sarah Ali discuss their inspiration and the origin of their unique collaboration: http://ow.ly/kwsf50Ix5UP
#100YearsOfInsulin
Bitter Sweet: Explore the highs, lows, hypers and hypos of living with type 1 #diabetes (#T1D) in this poetry and artwork collaboration between poet Duke Al and artist Dr Sarah Ali.
We’re delighted to support the launch of this groundbreaking new book, written to celebrate the anniversary of #100YearsOfInsulin and raise funds for Diabetes UK & JDRF UK
Find out more about this poignant and unique collection of poems and illustrations: http://ow.ly/Wcee50Ix436
Your medical research could be published in touchREVIEWS in Endocrinology in just 8-12 weeks.
We owe it to our 450+ database of faculty and high-profile Editorial Boards assisting with peer review decisions. They ensure authors, clinicians and HCPs are published quickly while maintaining the integrity, clinical balance and objectivity that’s led to our international renown.
Worthy medical research deserves a worthy home - find out more today: http://ow.ly/vyLx50ItTut
Why leading authors, clinicians and HCPs publish articles in touchREVIEWS in Endocrinology.
✅Trusted Publisher: Published under COPE, GPP3 and ICMJE guidelines to promote ethical, accurate, complete and transparent medical research reporting.
✅Thorough Review: Your manuscript is double-blind reviewed by at least 2 independent field experts for clinical balance, objectivity and relevance.
✅Quick Decision: Get notified if your manuscript is accepted within just 2-4 weeks after submission.
✅Fast Publication: Your article could be published online from 8-12 weeks after submission, pending peer review and acceptance.
✅Personal Service: Our journals team accept pre-submission enquiries, re-format articles and upload submissions on your behalf, speeding up the publication process.
Worthy medical research deserves a worthy home - find out more today: http://ow.ly/3uOW50Ir06q
Take a look as our experts in thyroid cancer share their perspectives on key issues relating to RET-altered thyroid cancer, including the value of biomarker testing, and targeted therapies for the personalised treatment of RET-altered thyroid cancers.
Watch now: http://ow.ly/KuuL50IlEBf
The University of Texas at Austin
Massachusetts General Hospital
MD Anderson Cancer Center
Funded by an independent medical education grant from Blueprint Medicines and Genentech, a member of the Roche Group. This activity is provided by touchIME.
#thyroidcancer
#diagnosticsandscreening
#headandneckcancer
#supportivecancercare
#meded
#endocrineoncology
#thyroiddisorders
